BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25344131)

  • 1. Child and adolescent Down syndrome-associated leukaemia: the Irish experience.
    O'Rafferty C; Kelly J; Storey L; Ryan C; O'Marcaigh A; Smith O
    Ir J Med Sci; 2015 Dec; 184(4):877-82. PubMed ID: 25344131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective study of myeloid leukaemia in children with Down syndrome in Ireland.
    Dowling GP; Piccin A; Gavin KT; Betts DR; Malone A; Cotter M; Sills A; Evans P; O' Marcaigh A; Smith OP
    Ir J Med Sci; 2020 Aug; 189(3):979-984. PubMed ID: 32006388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Leukemia in Down Syndrome Children in Hong Kong: Retrospective Review.
    Lam GK; Leung AW; Ha SY; Luk CW; Li CH; Ling SC; Chiang AK; Li CK
    J Pediatr Hematol Oncol; 2016 Mar; 38(2):102-6. PubMed ID: 26808367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute lymphoblastic leukemia in children with Down syndrome: Comparative analysis versus patients without Down syndrome.
    Pennella CL; Rossi JG; Baialardo EM; Alonso CN; Guitter MR; Sánchez La Rosa CG; Millán NC; Alfaro EM; Zubizarreta PA; Felice MS
    Arch Argent Pediatr; 2018 Aug; 116(4):e500-e507. PubMed ID: 30016023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term prognosis of children with Down's syndrome and leukaemia: a 34-year nation-wide experience.
    Rajantie J; Siimes MA
    J Intellect Disabil Res; 2003 Nov; 47(Pt 8):617-21. PubMed ID: 14641809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of treatment for relapsed acute lymphoblastic leukaemia in children with Down syndrome.
    Meyr F; Escherich G; Mann G; Klingebiel T; Kulozik A; Rossig C; Schrappe M; Henze G; von Stackelberg A; Hitzler J
    Br J Haematol; 2013 Jul; 162(1):98-106. PubMed ID: 23594030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin supplement use among children with Down's syndrome and risk of leukaemia: a Children's Oncology Group (COG) study.
    Blair CK; Roesler M; Xie Y; Gamis AS; Olshan AF; Heerema NA; Robison LL; Ross JA;
    Paediatr Perinat Epidemiol; 2008 May; 22(3):288-95. PubMed ID: 18426524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute leukaemia in children with Down syndrome: a population-based Nordic study.
    Zeller B; Gustafsson G; Forestier E; Abrahamsson J; Clausen N; Heldrup J; Hovi L; Jonmundsson G; Lie SO; Glomstein A; Hasle H;
    Br J Haematol; 2005 Mar; 128(6):797-804. PubMed ID: 15755283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group.
    Buitenkamp TD; Izraeli S; Zimmermann M; Forestier E; Heerema NA; van den Heuvel-Eibrink MM; Pieters R; Korbijn CM; Silverman LB; Schmiegelow K; Liang DC; Horibe K; Arico M; Biondi A; Basso G; Rabin KR; Schrappe M; Cario G; Mann G; Morak M; Panzer-Grümayer R; Mondelaers V; Lammens T; Cavé H; Stark B; Ganmore I; Moorman AV; Vora A; Hunger SP; Pui CH; Mullighan CG; Manabe A; Escherich G; Kowalczyk JR; Whitlock JA; Zwaan CM
    Blood; 2014 Jan; 123(1):70-7. PubMed ID: 24222333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of children and adolescents with Down syndrome treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00-001 and 05-001.
    Athale UH; Puligandla M; Stevenson KE; Asselin B; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Sulis ML; Welch JJG; Harris MH; Neuberg DS; Sallan SE; Silverman LB
    Pediatr Blood Cancer; 2018 Oct; 65(10):e27256. PubMed ID: 29878490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of patients with Down syndrome and acute leukemia: A retrospective observational study.
    Schmidt MP; Colita A; Ivanov AV; Coriu D; Miron IC
    Medicine (Baltimore); 2021 Oct; 100(40):e27459. PubMed ID: 34622870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of Down syndrome associated acute lymphoblastic leukaemia treated on a contemporary protocol.
    Patrick K; Wade R; Goulden N; Rowntree C; Hough R; Moorman AV; Mitchell CD; Vora A
    Br J Haematol; 2014 May; 165(4):552-5. PubMed ID: 24428704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supportive care utilization and treatment toxicity in children with Down syndrome and acute lymphoid leukaemia at free-standing paediatric hospitals in the United States.
    Salazar EG; Li Y; Fisher BT; Rheingold SR; Fitzgerald J; Seif AE; Huang YS; Bagatell R; Aplenc R
    Br J Haematol; 2016 Aug; 174(4):591-9. PubMed ID: 27161549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute lymphoblastic leukaemia in children with Down syndrome: an updated review.
    Maloney KW
    Br J Haematol; 2011 Nov; 155(4):420-5. PubMed ID: 21933171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome for Down syndrome patients with hematopoietic disorders.
    Li MJ; Lee NC; Yang YL; Yen HJ; Chang HH; Chien YH; Lu MY; Jou ST; Lin KH; Hwu WL; Lin DT
    J Formos Med Assoc; 2016 Feb; 115(2):94-9. PubMed ID: 26234152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an iBFM-SG study.
    Forestier E; Izraeli S; Beverloo B; Haas O; Pession A; Michalová K; Stark B; Harrison CJ; Teigler-Schlegel A; Johansson B
    Blood; 2008 Feb; 111(3):1575-83. PubMed ID: 17971484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute lymphoblastic leukemia and Down syndrome: presenting features and treatment outcome in the experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP).
    Arico M; Ziino O; Valsecchi MG; Cazzaniga G; Baronci C; Messina C; Pession A; Santoro N; Basso G; Conter V;
    Cancer; 2008 Aug; 113(3):515-21. PubMed ID: 18521927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relapse, not regimen-related toxicity, was the major cause of treatment failure in 11 children with Down syndrome undergoing haematopoietic stem cell transplantation for acute leukaemia.
    Meissner B; Borkhardt A; Dilloo D; Fuchs D; Friedrich W; Handgretinger R; Peters C; Schrauder A; Schuster FR; Vormoor J; Maecker B; Sykora KW; Zintl F; Welte K; Sauer M
    Bone Marrow Transplant; 2007 Nov; 40(10):945-9. PubMed ID: 17768387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down's syndrome and acute lymphoblastic leukaemia: clinical features and response to treatment.
    Chessells JM; Harrison G; Richards SM; Bailey CC; Hill FG; Gibson BE; Hann IM
    Arch Dis Child; 2001 Oct; 85(4):321-5. PubMed ID: 11567943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down syndrome and acute lymphoblastic leukaemia.
    Whitlock JA
    Br J Haematol; 2006 Dec; 135(5):595-602. PubMed ID: 17054672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.